Time

11.30 – 12.15

SCSS AGM 2018

(Restricted to SCSS members only!)

12.15 – 13.00

Lunch Networking

13.00– 13.15

Welcome & Introduction to CTFG Launch

Ray DUNN & John DANGERFIELD

(Open to public)

13.15-14.55

Session 1

(Chair: Shigeki SUGII, Singapore Bioimaging Consortium)

13.15- 13.40

Glycosaminoglycans as Adjuvants for Enhanced Cellular Therapy

Simon COOL, Institute of Medical Biology, Singapore

13.40 – 14.05

Growing and Using Blood Stem Cells: Already a Reality

William HWANG, Singapore General Hospital

14.05 – 14.30

A Co-operative Framework for Encouraging Responsible Innovation with Autologous Cellular Therapies

Tamra LYSAGHT, National University of Singapore

14:30 – 14:55

The Next Generation of T Cell Therapy to Tackle the Solid Tumor Challenge

John CONNOLLY, TESSA Therapeutics, Singapore

14.55 – 15.30

Tea break

15.30 – 16:45

Session 2

(Chair: John DANGERFIELD, AustriaNova, Singapore)

15.30 – 15.55

TCR-T Cell Product Development Strategy from Lab to Market

Lietao Victor LI, Lion TCR, Singapore

15.55 – 16.20

An Overview of Cell-based Therapy in Malaysia

Angela NG, Universiti Kebangsaan Malaysia Medical Centre, Malaysia

16.20 – 16.45

Clinical Outcomes of Mesenchymal Stem Cell (MSC) Therapy for Cartilage Regeneration in Singapore

James HUI, National University Health System, Singapore

16:45 – 16:50

Announcement: Duke-NUS, BioLamina and Novo Nordisk enter collaborative research on stem cell-based therapy for heart and eye diseases

Karl Tryggvason, Duke-NUS, Singapore

16:50 – 17:30

Panel Discussion

Fostering Translational Research

(Moderators: Tamra LYSAGHT & Ray DUNN)

Panel members: James Hui, Simon Cool, John Connolly

17.30 – 19:00

Wine & Dinner networking